|
Customised approach useful in resolving
decentred ablations after LASIK and PRK
Cheryl Guttman in San Francisco, US
THE Custom Contoured Ablation Pattern (C-CAP, VISX) method is proving
itself to be an effective modality for addressing eyes with post-laser
vision correction surgery decentred ablations which would otherwise
be deemed untreatable, asserted Edward E Manche MD at the annual
ASCRS Symposium on Cataract, IOL and Refractive Surgery.
Dr Manche reported the outcomes he achieved in a series of 10 eyes
which had clinically significant decentred ablations after LASIK
in eight cases or PRK in two cases. follow-up was at least three
months in seven eyes.
Topographical maps showed all eyes benefited with improved centration
and regularisation of the cornea surface. All patients reported
reduction or resolution of visually disabling symptoms, which included
distortions, diplopia, ghosting, halos and glare.
Functionally,
BSCVA improved by at least two lines in eight eyes and remained
stable in the other two. Uncorrected visual acuity remained stable
or improved in nine of the 10 eyes. The single eye which lost UCVA
maintained BSCVA.
"These
limited results indicate C-CAP is achieving its clinical goals,
which are to regularise the corneal surface and thereby reduce disturbing
visual aberrations, enhance overall quality of vision and optimise
BSCVA.
"The procedure is not intended necessarily to improve uncorrected
vision and patients are informed preoperatively that they might
need another procedure as an enhancement to achieve that result,"
Dr Manche said.
He performed wavefront analyses using the WavePrint system (VISX)
in five eyes. These studies showed the C-CAP treatment improved
higher order aberrations in all cases. Mean RMS for total higher
order aberrations decreased significantly by 45.5% from 0.66 microns
pre-C-CAP to 0.36 microns after treatment.
However, Dr Manche noted that C-CAP should be considered an adjunct
to fully customised wavefront-guided ablation, not a substitute.
"It is not possible to obtain good wavefront data in an appreciable
proportion of these highly aberrated eyes, and without adequate
imaging, it would not be possible to treat those cases with wavefront-guided
custom ablation.
"However, C-CAP can be complementary to customised wavefront
treatment, used first to regularise the corneal surface, allowing
a follow-up wavefront-guided treatment or conventional LASIK as
a fine-tuning procedure," he explained.
C-CAP is performed using the elevation map produced by the Zeiss-Humphrey
Atlas Topography system which allows the surgeon to analyse the
decentred ablation and identify the appropriate treatment area.
Then, using the Vision Pro ablation planning software of the topography
unit, the surgeon selects the size, shape, depth and location (on
or off-axis) for a series of up to 20 sequential ablations.
To perform C-CAP, refractive surgeons need training and certification
from VisX. Using the cornea elevation maps and the ablation planning
software, they are able to identify the area of decentration, analyse
it and select their treatment ablation parameters.
The software will simulate the planned ablation and produce a corresponding
postoperative topography map, allowing the surgeon to test the parameters
selected and adjust them to achieve a satisfactory result before
proceeding.
"The software performs reasonably well in predicting the postoperative
topography results, but there is a learning curve for using it.
I have now treated about 14 eyes and the planning process takes
me 15 to 20 minutes per case. Initially, however, I was spending
about an hour planning and revising simulated ablations," Dr
Manche said.
He added that his own approach was a conservative one at first in
which he tried to minimise the amount of tissue removal. After performing
a few cases and learning how the simulated results corresponded
with the actual outcomes, he said he has become a little more aggressive.
"I was very careful because I wanted to avoid creating any
divots that would be untreatable. My experience showed me the planning
software tended to overestimate the amount of tissue removed and
so there was less risk for over-ablation and producing a divot.
"Therefore, I became more aggressive with my ablations because
initially I was able to regularise the cornea surface but was not
completely eliminating the topographical decentrations," he
explained.
Edward
Manche MD
Stanford University School of Medicine, California, US
edward.manche@stanford.edu
|